Recipient Pre-HSCT Treatment with TNFRSF25 and CD25 Agonists Ameliorates Gvhd in a Host Treg Dependent Manner Following Murine MHC-Mismatched Transplantation
Recipient Pre-HSCT Treatment with TNFRSF25 and CD25 Agonists Ameliorates Gvhd in a Host Treg Dependent Manner Following Murine MHC-Mismatched Transplantation
Creators
Casey O. Lightbourn
Henry Barreras Jr
Dietlinde Wolf
Geoffrey R Hill
Krishna V. Komanduri
Sabrina N. Copsel
Robert B. Levy
Publication Details
Transplantation and cellular therapy, Vol.28(3), pp.S276-S277
Academic Unit
UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine; Microbiology and Immunology Research